Comments
MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2019 ,inter alia, to consider and approve The Board Meeting of the Company is scheduled to be held on Tuesday, 28th May, 2019 at New Delhi to transact, apart from other Agenda items, the following businesses: 1 To consider, approve and take on record the Audited financial statements for the year ended 31" March, 2019 & Audited Financial results for the quarter and year ended 31ST March, 2019. 2. To receive and take on record the Auditors Report on Annual Accounts for the same period. We further inform you that as per the Companys Code of Internal Procedure and Conduct for regulating, monitoring and reporting of trading by insiders, adopted by the Board of Directors pursuant to SEBI {Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company was closed for the Specified Persons from 03rd April, 2019 till 48 hours after the announcement/declaration of the Audited Financial Results of the Company for the quarter and year ended March 31, 2019
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.